About Edward Mathers
Form D filings for Brenig Therapeutics in 2024 list Edward Mathers as director.
Edward Mathers first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Edward Mathers in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Edward Mathers works with at each company, as listed on that company's latest Form D.
Brenig Therapeutics, Inc. · Form D, Jul 30, 2024
KG
Keno Gutierrez
Director
ID
Iain Dukes
Executive officer and director
NS
Nikolay Savchuk
Chief Executive Officer and director
MC
Michele Cucullu
Director